Overview of SARS-CoV-2 infection in adults living with HIV
dc.contributor.author | Ambrosioni, Juan | |
dc.contributor.author | Blanco, José Luis | |
dc.contributor.author | Reyes-Urueña, Juliana M | |
dc.contributor.author | Davies, Mary-Ann | |
dc.contributor.author | Sued, Omar | |
dc.contributor.author | Marcos, Maria Angeles | |
dc.contributor.author | Martínez, Esteban | |
dc.contributor.author | Bertagnolio, Silvia | |
dc.contributor.author | Alcamí, Jose | |
dc.contributor.author | Miró, Jose M | |
dc.contributor.author | COVID-19 in HIV Investigators | |
dc.date.accessioned | 2024-05-23T23:49:19Z | |
dc.date.available | 2024-05-23T23:49:19Z | |
dc.date.issued | 2021-05-08 | |
dc.description | Fil: Sued O. Fundación Huésped, Buenos Aires; Argentina | es_ES |
dc.description.abstract | Around 2·5 million deaths and more than 110 million COVID-19 cases have been reported globally. Although it initially appeared that HIV infection was not a risk factor for COVID-19 or more severe disease, more recent large studies suggest that people living with HIV (particularly with low CD4 cell counts or untreated HIV infection) might have a more severe clinical course than those who are HIV-negative. Moreover, the COVID-19 pandemic has disrupted HIV prevention and treatment services worldwide, creating huge challenges to the continuity of essential activities. We have reviewed the most relevant features of COVID-19 in people living with HIV and highlighted topics where further research is required. | es_ES |
dc.format | application/pdf | es_ES |
dc.identifier.doi | https://doi.org/10.1016/s2352-3018(21)00070-9 | |
dc.identifier.uri | https://repositorio.huesped.org.ar/handle/123456789/1340 | |
dc.language | ENG | es_ES |
dc.provenance | Published | es_ES |
dc.relation.ispartofseries | Lancet HIV;2021 May;8(5):e294-e305. | |
dc.rights | openAccess | es_ES |
dc.subject | COVID-19 | es_ES |
dc.subject | HIV | es_ES |
dc.title | Overview of SARS-CoV-2 infection in adults living with HIV | es_ES |
dc.type | Articulo | es_ES |